Protonation-triggered cyclization constructs complex polycyclic frameworks in natural products, suggesting a novel method for drug development.
N-containing polycyclic frameworks possessing consecutive chiral centers are widely found in a broad range of natural products and important bioactive molecules. Stereoselectively constructing their complex polycyclic frameworks represents a long-standing challenge. Herein, protonation of ynamide-initiated polyene cyclization was employed to construct such complex N-containing polycyclic skeletons, which are inaccessible or require tedious multiple-step strategies otherwise, with excellent stereoselectivity from a linear precursor. DFT calculations have been applied to understand the reaction mechanism, finding that a nonclassical carbocation intermediate with a cyclopropane ring is critical for controlling the diastereoselectivity of the present cyclization.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: